24 results
8-K
EX-3.1
ZVRA
Zevra Therapeutics Inc
28 Feb 24
Amendments to Articles of Incorporation or Bylaws
4:29pm
8-K
EX-3.1
ZVRA
Zevra Therapeutics Inc
23 Feb 23
Amendments to Articles of Incorporation or Bylaws
9:29pm
8-K
EX-3.2
ZVRA
Zevra Therapeutics Inc
23 Feb 23
Amendments to Articles of Incorporation or Bylaws
9:29pm
8-K
EX-3.1
ZVRA
Zevra Therapeutics Inc
23 Jun 21
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-3.2
ZVRA
Zevra Therapeutics Inc
23 Jun 21
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-3.3
8jcuanm 0q36jgza
23 Jun 21
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-3.1
7z1xt ew8
13 Jan 21
KemPharm Announces Pricing of $50 Million Public Offering of Common Stock and Warrants and Uplisting to The Nasdaq Capital Market
12:00am
8-K
EX-3.1
3iicdvb6e jn8kjcyhzc
28 Dec 20
KemPharm Announces 1-for-16 Reverse Stock Split
12:00am
8-K
EX-3.1
tsbxj
21 Dec 20
Entry into a Material Definitive Agreement
6:06am
8-K
EX-3.1
t1huh
18 Dec 19
KemPharm Announces Debt Restructuring with Deerfield and Delaware Street Capital
7:30am
8-K
EX-3.2
hyljfhk3xdfnuhedyy
4 Sep 19
Up to a Total of $493 Million in Upfront, Sales and Development Milestone Payments, as well as Royalties on Net Sales
8:01am
8-K
EX-3.1
o458sw2ksyc r9s7ce
4 Sep 19
Up to a Total of $493 Million in Upfront, Sales and Development Milestone Payments, as well as Royalties on Net Sales
8:01am
8-K
EX-3.1
sswu63imk0 x62jc
5 Oct 18
KemPharm Announces Pricing of Public Offering of Common Stock
10:03am
8-K
EX-3.1
82wcj
21 Apr 15
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
EX-3.2
5cx5o
21 Apr 15
Amendments to Articles of Incorporation or Bylaws
12:00am
S-1/A
EX-3.2
yzx1ms3gfpim7z 2j
3 Apr 15
IPO registration (amended)
12:00am
S-1
EX-3.4
hhwwmkcwnxos89
11 Mar 15
IPO registration
12:00am
S-1
EX-3.1
20xxp4
11 Mar 15
IPO registration
12:00am
S-1
EX-3.5
uwmro5lvzo9j pq177
11 Mar 15
IPO registration
12:00am